Keyphrases
Indonesia
63%
Radiation Therapy
58%
Cervical Cancer
49%
Referral Hospital
39%
Radiotherapy
34%
Cancer Patients
32%
Telomerase
26%
Radiosensitization
26%
Complete Response
18%
In Cancer
16%
Therapy Response
16%
Cancer-related
15%
Cervical Squamous Cell Carcinoma
15%
Cancer Epidemiology
13%
Squamous Cell Cervical Carcinoma
13%
Carbogen Breathing
13%
Radiotherapy Patients
13%
Patient Delay
13%
Bleeding Scale
13%
Cancer Registry Data
13%
Gallic Acid
13%
Oncolytic Viral Therapy
13%
Oncolytic Virus
13%
Manganese Superoxide Dismutase (MnSOD)
13%
Survivin
13%
Protein Intake
13%
Treatment Delay
13%
Invasive Cervical Cancer
13%
Response Predictors
13%
Precision Oncology
13%
Genomic Big Data
13%
Randomized Placebo-controlled Trial
13%
Cancer Study
13%
Nutritional Quality
13%
Hospital-based Cancer Registry
13%
Plan Revision
13%
Nicotinamide
13%
Prostate Cancer
13%
Intention-to-treat Analysis
13%
Cell Apoptosis
13%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
13%
Rapid Advancement
13%
Bleeding
13%
Head-and-neck Cancer
13%
Prognostic nutritional Index
13%
Squamous Cell Carcinoma (SqCC)
13%
DNA Repair
13%
Therapy Outcome
13%
Von Willebrand Factor
13%
Genomic Data
13%
Medicine and Dentistry
Radiation Therapy
100%
Malignant Neoplasm
59%
Cervical Cancer
50%
Patient Referral
39%
Squamous Cell Carcinoma
28%
Nasopharynx Cancer
26%
Telomerase
26%
Neoplasm
18%
Cancer Stem Cell
16%
Quality of Life
14%
Carbogen
13%
Therapy Delay
13%
Von Willebrand Factor
13%
Bleeding
13%
Head and Neck Cancer
13%
Protein Intake
13%
Oncolytic Virus
13%
Oncolytic Virotherapy
13%
Nicotinamide
13%
Intention-to-Treat Analysis
13%
Lymphadenopathy
13%
Adaptive Radiotherapy
13%
Oncology
13%
Cancer Cell Line
13%
Whole Brain Radiotherapy
13%
Breathing
13%
Survivin
13%
Radiosensitizer
13%
DNA Repair
13%
Treatment Response
13%
Systematic Review
13%
Uterine Cervix Carcinoma
13%
Cancer Registry
13%
Placebo
13%
Dosimetry
13%
Chemoradiotherapy
13%
Squamous Cell
13%
Cancer Epidemiology
13%
Radiation Response
9%
Malonaldehyde
9%
Survival Rate
8%
Programmed Cell Death
7%
Prognostic Factor
6%
Personalized Medicine
6%
Immunocompetent Cell
6%
Medical Oncology
6%
The Cancer Genome Atlas
6%
Hemostat
5%
Cell Marker
5%
Radiosensitivity
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
44%
Uterine Cervix Cancer
44%
Squamous Cell Carcinoma
26%
Radiosensitizing Agent
26%
Carbogen
13%
Nasopharynx Cancer
13%
Cancer Epidemiology
13%
Head and Neck Cancer
13%
Manganese Superoxide Dismutase
13%
Oncolytic Virus
13%
Gallic Acid
13%
Brain Metastasis
13%
Survivin
13%
Preclinical Study
13%
Placebo
13%
Prostate Cancer
13%
Malonaldehyde
13%
Telomerase
13%
Nicotinamide
13%
Cancer Registry
13%
Chemoradiation Therapy
13%
Clinical Trial
13%
Neoplasm
10%
Symptom
6%
Cohort Study
6%
Cognitive Defect
6%
Observational Study
6%
Comorbidity
6%
Side Effect
6%
Randomized Clinical Trial
6%
Cross-Sectional Study
6%
Survival Rate
6%